Use Able AI chat for product recommendations

MIEN1 Recombinant monoclonal antibody, PBS Only

MIEN1 Uni-rAb® Recombinant Antibody for WB, Indirect ELISA

Cat No. 87911-1-PBS
Clone No.252392C9

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, Indirect ELISA

C17orf37, C35, HBV XAg-transactivated protein 4, HBV X-transactivated gene 4 protein, Migration and invasion enhancer 1

Formulation:  PBS Only
Conjugate:  Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Product Information

87911-1-PBS targets MIEN1 in WB, Indirect ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen

CatNo: Eg5748

Product name: Recombinant Human MIEN1 protein (rFc Tag)

Source: mammalian cells-derived, V37

Tag: C-rFc

Domain: 2-115 aa of NM_032339.5

Sequence: SGEPGQTSVAPPPEEVEPGSGVRIVVEYCEPCGFEATYLELASAVKEQYPGIEIESRLGGTGAFEIEINGQLVFSKLENGGFPYEKDLIEAIRRASNGETLEKITNSRPPCVIL

Predict reactive species
Full Name chromosome 17 open reading frame 37
Calculated Molecular Weight12 kDa
Observed Molecular Weight12 kDa
GenBank Accession NumberNM_032339.5
Gene Symbol C17orf37
Gene ID (NCBI) 84299
RRIDAB_3745822
Conjugate Unconjugated
FormLiquid
Purification MethodProtein A purification
UNIPROT IDQ9BRT3
Storage Buffer PBS only, pH 7.3.
Storage ConditionsStore at -80°C.

Background Information

MIEN1 (Migration and Invasion Enhancer 1), also known as C17orf37 or RDEP, is a protein-coding gene located in the q12 region of chromosome 17. Through prenylation modification, this protein anchors to the inner side of the cell membrane, promotes actin cytoskeleton rearrangement and membrane ruffling, thereby enhancing the migration and invasion capabilities of tumor cells. MIEN1 is highly expressed in various malignant tumors, including breast cancer, prostate cancer, and lung cancer, and its expression level is closely correlated with tumor metastasis, clinical stage, and poor patient prognosis. Moreover, MIEN1 promotes epithelial-mesenchymal transition (EMT) by regulating signaling pathways such as PI3K/AKT and NF-κB, making it a potential anti-metastatic therapeutic target and prognostic marker.

Loading...
||
New chat

Able

正在加载,请稍候...